Edwards Lifesciences Corporation Stock price

Equities

EW

US28176E1082

Advanced Medical Equipment & Technology

Market Closed - Nyse 04:00:02 2024-03-18 pm EDT 5-day change 1st Jan Change
92.85 USD +0.58% Intraday chart for Edwards Lifesciences Corporation +2.22% +21.77%
Sales 2024 * 6.52B Sales 2025 * 7.17B Capitalization 55.83B
Net income 2024 * 1.62B Net income 2025 * 1.82B EV / Sales 2024 * 8.22 x
Net cash position 2024 * 2.23B Net cash position 2025 * 3.62B EV / Sales 2025 * 7.29 x
P/E ratio 2024 *
34.6 x
P/E ratio 2025 *
30.9 x
Employees 19,800
Yield 2024 *
-
Yield 2025 *
-
Free-Float 91.6%
More Fundamentals * Assessed data
Dynamic Chart
Oppenheimer Raises Edwards Lifesciences Price Target to $100 From $93, Maintains Outperform Rating MT
Edwards Lifesciences Insider Sold Shares Worth $1,319,696, According to a Recent SEC Filing MT
Edwards Lifesciences Insider Sold Shares Worth $1,320,149, According to a Recent SEC Filing MT
Edwards Lifesciences Announces Large, Real-World Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR CI
North American Morning Briefing : Stock Futures -2- DJ
BofA Securities Upgrades Edwards Lifesciences to Buy From Neutral, Adjusts Price Target to $105 From $97 MT
Transcript : Edwards Lifesciences Corporation Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-05-2024 10:30 AM
Edwards Lifesciences Insider Sold Shares Worth $2,543,737, According to a Recent SEC Filing MT
Edwards Lifesciences Insider Sold Shares Worth $620,923, According to a Recent SEC Filing MT
Edwards Lifesciences Insider Sold Shares Worth $267,911, According to a Recent SEC Filing MT
Edwards Lifesciences Insider Sold Shares Worth $711,272, According to a Recent SEC Filing MT
Edwards Lifesciences Insider Sold Shares Worth $4,040,854, According to a Recent SEC Filing MT
Edwards Lifesciences Insider Sold Shares Worth $944,155, According to a Recent SEC Filing MT
US FDA staff raises no new concerns about Abbott's heart device RE
Edwards Lifesciences Insider Sold Shares Worth $609,991, According to a Recent SEC Filing MT
More news
1 day+0.58%
1 week+0.77%
Current month+9.40%
1 month+7.84%
3 months+20.74%
6 months+26.84%
Current year+21.77%
More quotes
1 week
89.79
Extreme 89.79
95.27
1 month
83.61
Extreme 83.61
95.27
Current year
71.67
Extreme 71.67
95.27
1 year
60.57
Extreme 60.57
95.27
3 years
60.57
Extreme 60.57
131.73
5 years
51.51
Extreme 51.5067
131.73
10 years
11.72
Extreme 11.715
131.73
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 14-12-31
Chairman 71 99-12-31
Director of Finance/CFO 57 13-12-31
Members of the board TitleAgeSince
Director/Board Member 63 16-07-04
Director/Board Member 67 14-11-12
Director/Board Member 72 16-03-15
More insiders
Date Price Change Volume
24-03-18 92.85 +0.58% 2,899,680
24-03-15 92.31 -1.12% 5,700,263
24-03-14 93.36 +0.46% 5,066,707
24-03-13 92.93 +2.22% 7,036,488
24-03-12 90.91 +0.09% 2,323,870

Delayed Quote Nyse, March 18, 2024 at 04:00 pm EDT

More quotes
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - hemodynamic monitoring systems (65.4%); - heart valves and surgery products (18.7%); - other (15.9%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.2%), Europe (21.8%), Japan (8.8%) and other (11.2%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
92.85 USD
Average target price
91.82 USD
Spread / Average Target
-1.10%
Consensus
  1. Stock
  2. Equities
  3. Stock Edwards Lifesciences Corporation - Nyse